During a House Oversight Committee hearing, FDA Commissioner Dr. Robert Califf was pressed by Representative Ro Khanna on issues concerning the FDA's oversight and potential conflicts of interest with Big Pharma. Dr. Califf highlighted the FDA's focus on "preventing and mitigating supply chain issues" in regulated industries. Additionally, he urged lawmakers to pass legislation requiring food manufacturers to test for lead in products imported from overseas. Representative Khanna specifically asked Dr. Califf to commit not to accept consulting fees from Big Pharma after leaving office, emphasizing the importance of maintaining integrity in the FDA's regulatory role. Dr. Califf did not commit to not working for Big Pharma.
CSPAN - 4/11/2024 - @RoKhanna asks @US_FDA regulator if he would commit to not taking money from Big Pharma after he leaves government He doesn't commit to not working for Big Pharma https://t.co/ldVbKQSCRI
The head of the U.S. Food and Drug Administration (FDA), Dr. Robert Califf, pushed lawmakers to pass a bill that would mandate that food manufacturers perform testing for lead in their products that are getting imported into the country from overseas. https://t.co/5LG8xtCe5g https://t.co/xdLnFx75bH
Representative Ro Khanna just asked the FDA Commissioner to commit to not accept money from big pharma in the future. Watch his response here: https://t.co/nGPmqXFe9C
I pressed FDA Commissioner Dr. Robert Califf to make a commitment not to accept Big Pharma consulting fees after he leaves office. If you're regulating Big Pharma, you shouldn't be taking money from Big Pharma. Period. https://t.co/e9dl2jMC0H
"Preventing and mitigating supply chain issues in the industries we regulate has been a primary focus" of the FDA. -- @DrCaliff_FDA https://t.co/w9xTzxGmzZ
House Oversight cmte hearing on oversight of the FDA w/FDA Commissioner Dr. Robert Califf